SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
-14.07%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$2.6B
AUM Growth
+$354M
(+16%)
Cap. Flow
+$679M
Cap. Flow
% of AUM
26.12%
Top 10 Holdings %
Top 10 Hldgs %
12.89%
Holding
1,318
New
552
Increased
277
Reduced
191
Closed
280
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$31.8M |
| 2 |
Plains GP Holdings
PAGP
|
$24.1M |
| 3 |
Cheniere Energy
LNG
|
$23M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$22.5M |
| 5 |
iShares US Real Estate ETF
IYR
|
$21.7M |
Top Sells
| 1 |
Fortive
FTV
|
$24M |
| 2 |
Tandem Diabetes Care
TNDM
|
$22.7M |
| 3 |
CCC.U
Churchill Capital Corp
CCC.U
|
$20.3M |
| 4 |
International Flavors & Fragrances
IFF
|
$16.3M |
| 5 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$14.6M |
Sector Composition
| 1 | Healthcare | 18.41% |
| 2 | Industrials | 14.3% |
| 3 | Consumer Discretionary | 13.15% |
| 4 | Technology | 10.74% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Intuit
INTU
$188B
| – | – |
-5,510
| Closed | -$1.25M |
|
1302
Interpublic Group of Companies
IPG
$9.94B
| – | – |
-30,700
| Closed | -$702K |
|
1303
IRIDEX
IRIX
$23.8M
| – | – |
-125,000
| Closed | -$794K |
|
1304
ITT
ITT
$13.3B
| – | – |
-191,034
| Closed | -$11.7M |
|
1305
Invesco Mortgage Capital
IVR
$529M
| – | – |
-5,570
| Closed | -$881K |
|
1306
Jacobs Solutions
J
$17.4B
| – | – |
-10,518
| Closed | -$666K |
|
1307
Johnson Controls International
JCI
$69.5B
| – | – |
-39,142
| Closed | -$1.37M |
|
1308
JPMorgan Chase
JPM
$809B
| – | – |
-32,889
| Closed | -$3.71M |
|
1309
KeyCorp
KEY
$20.8B
| – | – |
-133,700
| Closed | -$2.66M |
|
1310
Kraft Heinz
KHC
$32.3B
| – | – |
-20,000
| Closed | -$1.1M |
|
1311
Kinder Morgan
KMI
$59.1B
| – | – |
-20,100
| Closed | -$356K |
|
1312
Kennametal
KMT
$1.67B
| – | – |
-47,000
| Closed | -$2.05M |
|
1313
KRONOS Worldwide
KRO
$713M
| – | – |
-21,500
| Closed | -$350K |
|
1314
Kura Oncology
KURA
$713M
| – | – |
-266,300
| Closed | -$4.66M |
|
1315
Loews
L
$20B
| – | – |
-165,900
| Closed | -$8.33M |
|
1316
Lazard
LAZ
$5.32B
| – | – |
-17,600
| Closed | -$847K |
|
1317
Leggett & Platt
LEG
$1.35B
| – | – |
-8,100
| Closed | -$355K |
|
1318
Littelfuse
LFUS
$6.51B
| – | – |
-1,595
| Closed | -$316K |
|